arrow
返回
D

David Bushnell

University of Iowa

45H指数
340论文数
1.1W被引数
收录论文 28
发表时间
ASO Visual Abstract: Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors
err2024-11-23
err0
PREAI
errBorbon, Luis C.; Sherman, Scott K.; Breheny, Patrick J.; Chandrasekharan, Chandrikha; Menda, Yusuf; Bushnell, David; Bellizzi, Andrew M.; Ear, Po H.; O'Dorisio, M. Sue; O'Dorisio, Thomas M.; Dillon, Joseph S.; Howe, James R.
err分享
err收藏
Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors
err2024-11-06
err2
PREAI
errBorbon, Luis C.; Sherman, Scott K.; Breheny, Patrick J.; Chandrasekharan, Chandrikha; Menda, Yusuf; Bushnell, David; Bellizzi, Andrew M.; Ear, P. H.; O'Dorisio, M. Sue; O'Dorisio, Thomas M.; Dillon, Joseph S.; Howe, James R.
err分享
err收藏
Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis
err2023-12-21
err4
errOAAI
errFriebe, Liene; Freitag, Martin T.; Braun, Martin; Nicolas, Guillaume; Bauman, Andreas; Bushnell, David; Christ, Emanuel; Wild, Damian
err分享
err收藏
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting2021国家癌症研究所神经内分泌肿瘤临床试验计划会议共识报告
err2023-05-31
err1
errOAAI
errSingh, Simron; Hope, Thomas A.; Bergsland, Emily B.; Bodei, Lisa; Bushnell, David L.; Chan, Jennifer A.; Chasen, Beth R.; Chauhan, Aman; Das, Satya; Dasari, Arvind; Del Rivero, Jaydira; El-Haddad, Ghassan; Goodman, Karyn A.; Halperin, Daniel M.; Lewis, Mark A.; Lindwasser, O. Wolf; Myrehaug, Sten; Raj, Nitya P.; Reidy-Lagunes, Diane L.; Soares, Heloisa P.; Strosberg, Jonathan R.; Kohn, Elise C.; Kunz, Pamela L.
err分享
err收藏
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy镥-177 (Lu-177) DOTATATE治疗的实践参数
err2022-06-01
err4
PREAI
errLove, Charito; Desai, Neil B.; Abraham, Tony; Banks, Kevin P.; Bodei, Lisa; Boike, Thomas; Brown, Richard K. J.; Bushnell, David L.; DeBlanche, Lorraine E.; Dominello, Michael M.; Francis, Tony; Grady, Erin C.; Hobbs, Robert F.; Hope, Thomas A.; Kempf, Jeffrey S.; Pryma, Daniel A.; Rule, William; Savir-Baruch, Bital; Sethi, Ila; Subramaniam, Rathan M.; Xiao, Ying; Schechter, Naomi R.
err分享
err收藏
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
err2021-03-26
err15
errOAAI
errStrosberg, Jonathan R.; Srirajaskanthan, Rajaventhan; El-Haddad, Ghassan; Wolin, Edward M.; Chasen, Beth R.; Kulke, Matthew H.; Bushnell, David L.; Caplin, Martyn E.; Baum, Richard P.; Hendifar, Andrew E.; Oberg, Kjell; Ruszniewski, Philippe; Santoro, Paola; Broberg, Per; Leeuwenkamp, Oscar R.; Krenning, Eric P.
err分享
err收藏
Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
err2021-01-30
err11
errOAAI
errBushnell, David L.; Bodeker, Kellie L.; O'Dorisio, Thomas M.; Madsen, Mark T.; Menda, Yusuf; Graves, Stephen; Zamba, Gideon K. D.; O'Dorisio, M. Sue
err分享
err收藏
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
err2020-03-02
err84
errOAAI
errStrosberg, Jonathan; Kunz, Pamela L.; Hendifar, Andrew; Yao, James; Bushnell, David; Kulke, Matthew H.; Baum, Richard P.; Caplin, Martyn; Ruszniewski, Philippe; Delpassand, Ebrahim; Hobday, Timothy; Verslype, Chris; Benson, Al; Srirajaskanthan, Rajaventhan; Pavel, Marianne; Mora, Jaume; Berlin, Jordan; Grande, Enrique; Reed, Nicholas; Seregni, Ettore; Paganelli, Giovanni; Severi, Stefano; Morse, Michael; Metz, David C.; Ansquer, Catherine; Courbon, Frederic; Al-Nahhas, Adil; Baudin, Eric; Giammarile, Francesco; Taieb, David; Mittra, Erik; Wolin, Edward; O'Dorisio, Thomas M.; Lebtahi, Rachida; Deroose, Christophe M.; Grana, Chiara M.; Bodei, Lisa; Oberg, Kjell; Polack, Berna Degirmenci; He, Beilei; Mariani, Maurizio F.; Gericke, Germo; Santoro, Paola; Erion, Jack L.; Ravasi, Laura; Krenning, Eric
err分享
err收藏
NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE用177Lu-DOTATATE进行基于生长抑素受体的肽受体放射性核素治疗的NANETS/SNMMI程序标准
err2019-07-01
err107
errOAAI
errHope, Thomas A.; Abbott, Amanda; Colucci, Karen; Bushnell, David L.; Gardner, Linda; Graham, William S.; Lindsay, Sheila; Metz, David C.; Pryma, Daniel A.; Stabin, Michael G.; Strosberg, Jonathan R.
err分享
err收藏
90Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide TherapyDosimetry-
err2018-03-09
err31
errOAAI
errMenda, Yusuf; Madsen, Mark T.; O'Dorisio, Thomas M.; Sunderland, John J.; Watkins, G. Leonard; Dillon, Joseph S.; Mott, Sarah L.; Schultz, Michael K.; Zamba, Gideon K. D.; Bushnell, David L.; O'Dorisio, M. Sue
err分享
err收藏
Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor
err2017-02-02
err31
errOAAI
errMenda, Yusuf; O'Dorisio, Thomas M.; Howe, James R.; Schultz, Michael; Dillon, Joseph S.; Dick, David; Watkins, G. Leonard; Ginader, Timothy; Bushnell, David L.; Sunderland, John J.; Zamba, Gideon K. D.; Graham, Michael; O'Dorisio, M. Sue
err分享
err收藏
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors177Lu-Dotatate治疗中肠神经内分泌肿瘤的3期试验
err2017-01-12
err2.2K
errOAAI
errStrosberg, J.; El-Haddad, G.; Wolin, E.; Hendifar, A.; Yao, J.; Chasen, B.; Mittra, E.; Kunz, P. L.; Kulke, M. H.; Jacene, H.; Bushnell, D.; O'Dorisio, T. M.; Baum, R. P.; Kulkarni, H. R.; Caplin, M.; Lebtahi, R.; Hobday, T.; Delpassand, E.; Van Cutsem, E.; Benson, A.; Srirajaskanthan, R.; Pavel, M.; Mora, J.; Berlin, J.; Grande, E.; Reed, N.; Seregni, E.; Oberg, K.; Sierra, M. Lopera; Santoro, P.; Thevenet, T.; Erion, J. L.; Ruszniewski, P.; Kwekkeboom, D.; Krenning, E.
err分享
err收藏
Neuroendocrine tumours - personalised diagnosis and treatment using radiolabelled peptides
err2016-04-01
err0
errOAAI
errBaum, R. P.; Strosberg, J.; Wolin, E.; Chasen, B.; Kulke, M.; Bushnell, D.; Caplin, M.; Hobday, T.; Hendifar, A.; Oberg, K.; Sierra, M. Lopera; Kwekkeboom, D.; Ruszniewsk, P.; Krenning, E.; Mittra, E.
err分享
err收藏
177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial
err2015-09-01
err21
PREAI
errStrosberg, J.; Wolin, E.; Chasen, B.; Kulke, M.; Bushnell, D.; Caplin, M.; Baum, R. P.; Mittra, E.; Hobday, T.; Hendifar, A.; Oberg, K.; Sierra, M. Lopera; Ruszniewski, P.; Kwekkeboom, D.
err分享
err收藏
Feasibility and advantage of adding 131I-MIBG to 90Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors
err2014-09-10
err11
errOAAI
errBushnell, David L.; Madsen, Mark T.; O'cdorisio, Thomas; Menda, Yusuf; Muzahir, Saima; Ryan, Randi; O'dorisio, M. Sue
err分享
err收藏
A Diagnostic Dilemma of Atypical Gallbladder Appearance on Tc-99m HIDA Cholescintigraphy Resolved With SPECT/CT
err2011-02-01
err7
PREAI
errSood, Ravi; Murguia, Jeff; Graham, Michael M.; Bushnell, David; Squires, Shayne; Laroia, Sandeep T.; Bansal, Anish
err分享
err收藏
err分享
err收藏
Phase I Trial of 90Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors
err2010-09-16
err58
errOAAI
errMenda, Yusuf; O'Dorisio, M. Sue; Kao, Simon; Khanna, Geetika; Michael, Stacy; Connolly, Mary; Babich, John; O'Dorisio, Thomas; Bushnell, David; Madsen, Mark
err分享
err收藏